Spironolactone Suspension
Product Images NDC 17856-1133

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 17856-1133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (17856 1133 01)

Image Description (17856 1133 01)
This text describes a Spironolactone oral suspension medication with a strength of 25mg per 5 mL. The packaging includes directions to refer to the package insert for indications and dosage schedule. It is meant for oral use only and should be stored within a specific temperature range. The dosage provided is 12.5mg per 2.5mL. It also mentions keeping the medication out of reach of children. The information includes the product's identification number, expiration date, and packaging details.*
FDA Label Image

Chemical Structure (Chemical Structure)

FDA Label Image

Figure 1. Survival By Treatment Group In Rales (Figure 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.